Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Q2 Unclaimed
Dove Medical Press Ltd
New Zealand
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is a journal indexed in SJR in Pharmacology and Internal Medicine with an H index of 71. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1762,2 €. The scope of the journal is focused on diabetes, obesity, metabolic syndrome. It has an SJR impact factor of 0,827 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,827.
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -


Categories:
Internal Medicine (Q2)
Pharmacology (Q2)
Price
1762,2 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,827
SJR Impact factor71
H Index425
Total Docs (Last Year)1146
Total Docs (3 years)18416
Total Refs3491
Total Cites (3 years)1114
Citable Docs (3 years)2.85
Cites/Doc (2 years)43.33
Ref/DocOther journals with similar parameters
Vascular Pharmacology Q2
AIDS Research and Therapy Q2
Drug Safety - Case Reports Q2
Expert Review of Anticancer Therapy Q2
Toxicology and Applied Pharmacology Q2
Compare this journals
Aims and Scope
Diabetes
Obesity
Metabolic syndrome
Comments